Gene engineering bacterium for strengthening metabolic pathway of synthesizing tryptophan
A technology of genetically engineered bacteria and tryptophan synthase, applied in genetic engineering, plant genetic improvement, bacteria, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] A recombinant plasmid containing a mutant of tryptophan synthase gene and phosphoglycerate dehydrogenase gene is prepared by the following method: using pET22b (+) single plasmid multi-gene tandem expression strategy to synthesize tryptophan The enzyme gene trpBA gene was concatenated with the phosphoglycerate dehydrogenase gene mutant M3serA gene to obtain a recombinant plasmid pET-T7 promoter-M3serA-T7promotor-trpBA-T7 terminator, which was named M3BAT-I. The construction process is shown in Figure 1.
[0026] The construction method of the serA gene mutant (M3serA gene) has been published in "Chinese Journal of Biochemistry and Molecular Biology" 2006, No. 10, pages 806-810.
[0027] The method for cloning the trpBA gene has been published on pages 12-14 of the first issue of "Biotechnology Letters" in 2006.
Embodiment 2
[0029] A genetically engineered bacterium with enhanced tryptophan synthesis and metabolism pathway is obtained by the following method: Infect the host bacterium Escherichisa coli 491 with λDE3 phage, and make the chromosome of the lysogenized bacterium named DE3-491 contain a Copy the T7 RNA polymerase gene controlled by lacUV5, and transfer a recombinant plasmid M3BAT-I containing tryptophan synthase gene and phosphoglycerate dehydrogenase gene mutant made in Example 1 into competent DE3-491 Afterwards, it became a genetically engineered bacterium named M3BAT-I+DE3-491 with enhanced tryptophan synthesis and metabolism pathway. Induced expression with IPTG, analyzed by SDS-PAGE, M3BAT-I can express 44kD, 37kD, 29kD proteins in DE3-491 (Figure 2), which correspond to tryptophan synthase β subunit and phosphoglycerate dehydrogenase M3 respectively Mutant, tryptophan synthase alpha subunit. Enzyme activity analysis showed that the activity of tryptophan synthetase was increase...
Embodiment 3
[0031] A kind of genetically engineered bacterium that knocks out the tryptophan synthetic metabolic pathway of tnaA gene and strengthens is obtained by the following method: (1) selecting tnaA gene upstream and downstream flanking sequence fragments and kanamycin resistance gene kan r , connected to construct the tandem gene cassette pET22b-tnaA5'-kan r -tnaA3', and the linearized fragment tnaA5'-kan r -tnaA3' replaces the tnaA gene on the chromosome of a genetically engineered bacterium (M3BAT-I+DE3-491) with enhanced tryptophan synthesis and metabolism pathway through the Red homologous recombination system, resulting in the loss of the normal function of the gene and obtaining tryptophan The acidase-deficient strain was named M3BAT-I+DE3-491ΔT.
[0032] PCR amplification (Figure 4) and sequence determination (Figure 5) confirmed that the tnaA gene had been successfully knocked out.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com